Medicinal chemistry

View all stories within this topic.

  • Gin and tonic
    The Mole

    Quinine

    1 November 2010

    Quinine was the first successful anti-malarial, but it is now more familiar to us as the bitter taste in tonic water, but what is the story?

  • Mars bar
    The Mole

    Chocolate

    1 July 2010

    That’s chemistry: The molecules behind Mars bars

  • Tomorrow's vaccines - designed and made in the lab
    Feature

    Synthetic vaccines

    1 May 2010

    The design of synthetic vaccines offers a more systematic approach to vaccine therapy for many illnesses, including cancer, and even drug addiction

  • A sailor using a telescope
    The Mole

    Lost at sea: could you find your way using alchemy?

    1 January 2010

    On screen chemistry with Jonathan Hare

  • Joseph Lister
    Feature

    Solving an infectious problem

    1 September 2009

    Joseph Lister's use of phenol as an antiseptic revolutionised surgical practice in the 19th century. But was he the first to use this antiseptic technique?

  • image - Feaure - Hargreaves - main
    Feature

    Catalysts for a green industry

    1 July 2009

    Chemists are working to develop new, longer-lasting catalysts to ensure industrial processes are cleaner, greener and more efficient

  • Kew's greenhouse
    The Mole

    Kew the celebrations

    1 May 2009

    The Royal Botanic Gardens, Kew, celebrates 250 years of horticulture and science.

  • Electrical discharges from the nerve cells in the brain
    Feature

    Epilepsy - beyond bromide

    1 May 2009

    An historical journey into the treatment of epilepsy, starting with potassium bromide 150 years ago

  • Feet on weighing scales
    The Mole

    Obesity – at what cost

    1 March 2009

    Do drugs have a part to play in controlling obesity?

  • mosquito
    The Mole

    Antimalarial drugs

    1 January 2009

    Approximately one million people die annually from malaria worldwide. Tragically, 90 per cent of these deaths are among the under-fives in sub-Saharan Africa, who have little if any access to adequate healthcare. Drugs are used to treat the disease but parasitic resistance to these drugs is growing, so what is ...